Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Flow-Through Testing Technology Expanded for HIV Diagnosis

By HospiMedica staff writers
Posted on 24 Dec 2007
A new range of rapid HIV testing products is being produced utilizing a new scientific test platform. More...


The core technology platform, which is the basis a new generation of infectious disease testing products, includes a rapid flow-through diagnostic device, assay, and multi-functional buffer.

The rapid diagnostic tests were developed by MedMira (Halifax, Canada) and are to be sold by the German company Vitest (Hennigsdorf, Germany). This is the first shipment of MedMira's private label product to a distributor in Europe. Under the private label agreement, Vitest will market and sell the new product under the Vitest brand and it will be a part of the Vitest suite of rapid testing products.

"Our rapid flow-through technology platform has an endless list of potential applications, for which our current product pipeline has barely scratched the surface,” said Hermes Chan, president and CEO of MedMira. "Our strategic goals involve the pursuit of a wide range of opportunities to diversify not only our own product portfolio, but also to make available a private label or OEM [original equipment manufacturer] capability to fill the needs of our partners. We are pleased to welcome Vitest as our first partner in this endeavor.”

MedMira is a developer and manufacturer of flow-through rapid diagnostics. The company's tests provide hospitals, labs, clinics, and individuals worldwide with reliable, rapid diagnosis for diseases such as HIV and hepatitis C in just three minutes. The company's tests are sold under the Reveal, MiraWell, MiraCare, and Multiplo brands. MedMira's rapid HIV test has achieved regulatory approvals in Canada, the United States, China, and the European Union.

The Maple Biosciences division of MedMira develops and commercializes diagnostic instruments based on two new biosensor-based technology platforms. Solutions developed by The Maple Biosciences division of MedMira enable routine laboratory tests to be performed in minutes, increasing laboratory automation, and streamlining the diagnosis of multiple conditions and diseases.


Related Links:
MedMira
Vitest

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Hematology Consumables
Bioblood Devices
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.